Systemic bioavailability and pharmacokinetics of the doxylamine-pyridoxine delayed-release combination (diclectin)

Therapeutic Drug Monitoring

Volumn 33, Issue 1, 2011, Pages 115-119

  Gill, Simerpal Kaur ^a   Garcia Bournissen, Facundo ^a   Koren, Gideon ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Diclectin; doxylamine succinate; pharmacokinetics; pyridoxal 5' phosphate; pyridoxine; therapeutic drug monitoring

Indexed keywords

BENDECTIN; DOXYLAMINE; DRUG METABOLITE; PYRIDOXAL; PYRIDOXAL 5 PHOSPHATE; PYRIDOXAMINE; PYRIDOXAMINE PHOSPHATE; PYRIDOXINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; COMPARATIVE STUDY; CONTROLLED STUDY; DELAYED RELEASE FORMULATION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG METABOLISM; FEMALE; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PRIORITY JOURNAL; TABLET; TANDEM MASS SPECTROMETRY;

ADULT; ANTIEMETICS; BIOLOGICAL AVAILABILITY; CANADA; DELAYED-ACTION PREPARATIONS; DOXYLAMINE; DRUG COMBINATIONS; FEMALE; HUMANS; NAUSEA; PREGNANCY; PREGNANCY COMPLICATIONS; PYRIDOXAL PHOSPHATE; PYRIDOXINE; TABLETS; VOMITING; YOUNG ADULT;

EID: 78751645491     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e3181ff8bc5     Document Type: Article

References (13)

1. Vellacott ID, Cooke EJ, James CE. Nausea and vomiting in early pregnancy. Int J Gynaecol Obstet. 1988;27:57-62.
2. Gadsby R, Barnie-Adshead AM, Jagger C. A prospective study of nausea and vomiting during pregnancy. Br J Gen Pract. 1993;43:245-248.
3. Attard CL, Kohli MA, Coleman S, et al. The burden of illness of severe nausea and vomiting of pregnancy in the United States. Am J Obstet Gynecol. 2002;186:S220-227.
4. Miller F. Nausea and vomiting in pregnancy: the problem of perception-is it really a disease? Am J Obstet Gynecol. 2002;186:S182-183.
5. Badell ML, Ramin SM, Smith JA. Treatment options for nausea and vomiting during pregnancy. Pharmacotherapy. 2006;26:1273-1287.
6. Mazzotta P, Stewart DE, Koren G, et al. Factors associated with elective termination of pregnancy among Canadian and American women with nausea and vomiting of pregnancy. JPsychosom Obstet Gynaecol. 2001;22:7-12.
7. Einarson A, Maltepe C, Boskovic R, et al. Treatment of nausea and vomiting in pregnancy: an updated algorithm. Can Fam Physician. 2007; 53:2109-2111. (Pubitemid 351198284)
8. Atanackovic G, Navioz Y, Moretti ME, et al. The safety of higher than standard dose of doxylamine-pyridoxine (Diclectin®) for nausea and vomiting of pregnancy. J Clin Pharmacol. 2001;41:842-845.
9. Mitchell D, Wagner C, Stone WJ, et al. Abnormal regulation of plasma pyridoxal 5'-phosphate in patients with liver disease. Gastroenterology. 1976;71:1043-1049.
10. Spannuth CL Jr, Warnock LG, Wagner C, et al. Increased plasma clearance of pyridoxal 5'-phosphate in vitamin B6-deficient uremic man. J Lab Clin Med. 1977;90:632-637.
11. 14C-labeled doxylamine succinate (Bendectin®) in the rhesus monkey. J Anal Toxicol. 1986;10:87-92.
12. Tarr JB, Tamura T, Stokstad EL. Availability of vitamin B6 and pantothenate in an average American diet in man. Am J Clin Nutr. 1981;34:1328-1337.
13. Boskovic R, Einarson A, Maltepe C, et al. Diclectin therapy for nausea and vomiting of pregnancy: effects of optimal dosing. J Obstet Gynaecol Can. 2003;25:830-833.